THÉRAPIE COMBINATOIRE ENGAGEANT DES ANTAGONISTES ALPHA5BETA1

• 收藏
• 分享

专利权人:

INC.;GENENTECH

发明人:

申请号：

EP07868188.9

公开号：

EP1989231B1

申请日:

2007.03.21

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention relates to the use of VEGF antagonists and alpha5beta1 antagonists for treating cancer and inhibiting angiogenesis and/or vascular permeability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to use of a VEGFR agonists and alpha5beta1 agonists to promote angiogenesis and vascular permeability. The present invention also relates to new anti-alpha5beta1 antibodies, compositions and kits comprising them and methods of making and using them.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/